C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2002
11/13/2002	EP0843557B1 Methods for detecting, identifying, isolating, and selectively labelling and targeting th1 lymphocytes by means of the lag-3 protein
11/13/2002	EP0806959B1 Method for preparing macrophages and kits therefor
11/13/2002	EP0697889B1 COMBINED TREATMENT OF IRON DEPLETION AND IgG ANTIBODY
11/13/2002	EP0693940B1 Hybrid genes for use in the production of t h?-independent cytotoxic t cells
11/13/2002	EP0606452B1 Vector vaccines of recombinant feline herpesvirus
11/13/2002	CN1379820A Lentiviral vectors for preparation of immunotherapeutical compositions
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379814A Embryonic or stem-like cell lines produced by cross species nuclear transpcantation and methods for enhancing mebryonic development by genetic alteration of donor cells or by tissue culture conditions
11/13/2002	CN1379783A Methods for increasing plant cell proliferation by functionally inhibiting plant cyclin inhibitor gene
11/13/2002	CN1379782A Subunit optimized fusion proteins
11/13/2002	CN1379041A Cytotoxin T lymphocyte
11/12/2002	US6480791 Parallel methods for genomic analysis
11/12/2002	US6479734 DNA fragment responsive to low temperatures and a plant transformed with the DNA fragment
11/12/2002	US6479732 cDNA of 4-coumarate: coenzyme a ligase and process for modifying lignin in plants
11/12/2002	US6479731 Pi-ta gene conferring fungal disease resistance to plants
11/12/2002	US6479730 DNA Ligase II orthologue uses thereof
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002	US6479635 Receptor activator of NF-κB
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479630 Human purinergic P2U receptor
11/12/2002	US6479292 Genetic alteration in plants using single-stranded oligodeoxynucleotide vectors
11/12/2002	US6479291 Cytoplasmic inhibition of gene expression by viral RNA
11/12/2002	US6479290 Chimeric adenoviral vectors
11/12/2002	US6479287 Method for transformation of cotton and organogenic regeneration
11/12/2002	US6479286 Methods and compositions for making dendritic cells from expanded populations of monocytes and for activating T cells
11/12/2002	US6479283 Stimulation, culture and preservation of pancreatic cells
11/12/2002	US6479273 Filtration method for separating viruses
11/12/2002	US6479270 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof
11/12/2002	US6479266 IKK-α proteins nucleic acids and methods
11/12/2002	US6479263 Method for detection of micrometastatic prostate cancer
11/12/2002	US6479261 Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells
11/12/2002	US6479258 Non-stochastic generation of genetic vaccines
11/12/2002	US6479254 Polypeptide for use in treatment of lymphadenopathy, autoimmune disease and graft versus host disease; antitumor agents
11/12/2002	US6479247 Antibody for use in the treatment of cancer and arthritis
11/12/2002	US6479072 Microfabricated membranes and matrices
11/12/2002	US6479064 Culturing different cell populations on a decellularized natural biostructure for organ reconstruction
11/12/2002	US6479052 Spray delivery of cells
11/12/2002	US6478967 Removal of contaminants from biological products
11/12/2002	CA2301171C A multicellular in vitro assay of angiogenesis
11/12/2002	CA2220684C Process for controlling sialylation of proteins produced by mammalian cell culture
11/12/2002	CA2176738C Method and composition for transfer of active tumor-specific immunization from an immunized allogeneic bone marrow donor
11/12/2002	CA2170515C Nucleotide sequences for novel protein tyrosine phosphatases
11/12/2002	CA2169635C Method, compositions and devices for administration of naked polynucleotides which encode biologically active peptides
11/12/2002	CA2062820C Monoclonal and polyclonal antibodies and test method for determination of fenitrothion and closely related organophosphates
11/12/2002	CA2055963C Chimeric fibroblast growth factor
11/12/2002	CA2045875C Monoclonal antibodies to mycosphaerella species
11/10/2002	CA2382463A1 Hepatitis c virus (hcv) ns5b rna polymerase and mutants thereof
11/07/2002	WO2002088706A2 Process for differential diagnosis of alzheimer's dementia and device therefor
11/07/2002	WO2002088366A1 Von willebrand factor (vwf)-cleaving enzyme
11/07/2002	WO2002088354A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use
11/07/2002	WO2002088351A1 Modified organs and cells for xenotransplantation
11/07/2002	WO2002088348A2 Lipid producing cells and uses thereof
11/07/2002	WO2002088347A2 Aav helper plasmids for helper virus-free packaging and pseudo typification of aav vectors
11/07/2002	WO2002088346A2 A system for inducible expression in eukaryotic cells
11/07/2002	WO2002088340A2 Alkaline protease variants and detergents and cleaning agents containing said alkaline protease variants
11/07/2002	WO2002088338A2 Method for replicating the hepatitis c virus
11/07/2002	WO2002088337A1 Olfactory ensheathing glia produced by introducing telomerase
11/07/2002	WO2002088336A2 Genetically modified yt cell line and use thereof
11/07/2002	WO2002088335A1 Stem cells and method of separating the same
11/07/2002	WO2002088334A1 Chimeric immunoreceptor useful in treating human cancers
11/07/2002	WO2002088333A1 Method of culturing collected biopsy cells
11/07/2002	WO2002088332A1 Small liver cell-rich colony, method of preparing the same, method of maturing the same into liver tissue and method of estimating drug function using the matured small liver cell-rich colony
11/07/2002	WO2002088331A1 Tridimensional biocompatible support structure for bioartificial organs and uses thereof
11/07/2002	WO2002088330A2 Neural progenitor cells
11/07/2002	WO2002088329A1 Culture system for mouse tracheal epithelial cells
11/07/2002	WO2002088328A2 Method for generating highly active human dendritic cells from monocytes
11/07/2002	WO2002088322A2 Cell adhesion and extracellular matrix proteins
11/07/2002	WO2002088319A2 Mini-adenoviral vector and methods of using same
11/07/2002	WO2002088317A2 Fusion molecules and methods for treatment of immune diseases
11/07/2002	WO2002088316A2 G-protein coupled receptors
11/07/2002	WO2002088307A2 Humanized antibodies
11/07/2002	WO2002088305A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
11/07/2002	WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002	WO2002088170A2 Cripto blocking antibodies and uses thereof
11/07/2002	WO2002088168A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
11/07/2002	WO2002087627A1 Maturation of antigen-presenting cells using activated t cells
11/07/2002	WO2002087626A1 Pharmaceutical compositions comprising dendritic cells for immunotherapy of autoimmune disease and treatment methods using the same
11/07/2002	WO2002087620A1 Chondrogenesis promoters
11/07/2002	WO2002087612A2 Use of stimulated peripheral blood mononuclear cells for treating cancerous diseases
11/07/2002	WO2002087511A2 Modulators of elastase inhibitor secretion
11/07/2002	WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002	WO2002087502A2 Antibodies abolish prion propagation and promote clearance of infectivity
11/07/2002	WO2002087499A2 Cells for detection of enteroviruses
11/07/2002	WO2002087411A2 Composite scaffolds and methods using same for generating complex tissue grafts
11/07/2002	WO2002087341A1 Novel self-inactivating (sin) lentiviral vectors
11/07/2002	WO2002087306A2 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
11/07/2002	WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002	WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002	WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002	WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002	WO2002029064A3 Method for establishing germ cell-specific gene expression
11/07/2002	WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002	WO2002028424A3 Kyberdrug as autovaccines with immune-regulating effects
11/07/2002	WO2002024930A3 Artificial ubiquitous chromatin opening elements (ucoe)
11/07/2002	WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002	WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002	WO2002012899A3 Peptides presented by cells
11/07/2002	WO2001092476A3 In vitro tissue test system

1 ... 1279 1280 1281 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 ... 1827